Making An Impression

| September 21, 2017

AesculaTech, a USC Viterbi startup, was invited to present at a prestigious Bay Area investor symposium.

Niki Bayat and Andrew Bartynski of AesculaTech (Photo courtesy of AesculaTech)

AesculaTech, an award-winning biomedical device company, recently presented at the prestigious Rosenman Symposium, the premier event for the San Francisco Bay Area’s medical device community.

The startup has developed a shape-adaptive smart-material to treat dry eye. The material solidifies as it heats to body temperature, enabling easy administration of personalized medical care.

AesculaTech was one of only 10 finalists selected to pitch investors at the symposium. The event took place June 21 at UC San Francisco’s Mission Bay campus.

As a result of its well-received presentation, AesculaTech has received access to an investor network and free services from a contract research agency.

“They found our idea very interesting and unique, especially our technology platform,” said Andrew Bartynski, Ph.D.  ChE ’16, who co-founded AesculaTech with Niki Bayat, a USC Viterbi doctoral candidate in chemical engineering.

AesculaTech recently presented at the LAVA’s First Look LA, sponsored by the Los Angeles Venture Association. The startup also participated in the Summer Smasher and Synchrotron accelerator program at the Viterbi Startup Garage, and made the finals of the Collegiate Inventors Competition. Additionally, the business competed in the Maseeh Entrepreneurship Prize Competition in 2015.

Continuing its rapid progress towards the clinic, the company is currently performing preclinical trials. The fledgling company has also begun manufacturing prototypes and is performing technology demonstrations at Harvard, MIT, UCLA, and Johns Hopkins.

“AesculaTech has the right combination of breakthrough, impactful technology and dedicated, smart co-founders that makes them an excellent VC prospect,” said USC Viterbi Professor Peter Beerel, MEPC executive director.

Published on September 21st, 2017

Last updated on March 31st, 2022

Share This Story